Prolonged imatinib mesylate therapy in patients with chronic phase CML refractory to interferon causes a reduction of the levels of bcr/abl transcript which is independent from the cytogenetic response to treatment / Rossi, G; Capucci, M; Micheletti, M; Spalenza, F; Zanella, Isabella; Albertini, Alberto; Cariani, E.. - In: BLOOD. - ISSN 0006-4971. - 100(2002), pp. 324B-325B.
Titolo: | Prolonged imatinib mesylate therapy in patients with chronic phase CML refractory to interferon causes a reduction of the levels of bcr/abl transcript which is independent from the cytogenetic response to treatment. |
Autori: | |
Data di pubblicazione: | 2002 |
Rivista: | |
Handle: | http://hdl.handle.net/11379/148524 |
Appare nelle tipologie: | 1.5 Abstract in rivista |
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.